NAB2 Antibody

What is NAB2 and what cellular functions does it regulate?

NAB2 (NGFI-A-binding protein 2) is an RNA-binding protein that primarily functions as a corepressor of transcription factor Egr-1/NGFI-A. It plays a critical role in maintaining gene expression balance by modulating NGFI-A activity, which is involved in essential cellular processes including cell division, differentiation, and apoptosis . Recent studies have revealed that NAB2 also participates in developmental control of axonogenesis and growth cone guidance, with NAB2-null neurons failing to project axons properly and displaying abnormal midline crossing behaviors . At the subcellular level, NAB2 is predominantly localized in the nucleus where it exerts its regulatory functions .

How does NAB2 contribute to neuronal development processes?

NAB2 plays a significant role in neuronal development, particularly in axonogenesis and axon guidance mechanisms. Research using Drosophila models has demonstrated that NAB2-null mutations result in distinct morphological abnormalities in mushroom body (MB) neurons. Specifically, these neurons fail to project axons into the α-lobe, while β-lobe axons inappropriately cross the midline into the contralateral hemisphere . These developmental defects become evident during critical windows of neuronal formation. At 48-72 hours after puparium formation (APF), NAB2-null Drosophila brains already display a high rate (85%) of missing/thinning α-lobes and fused/missing β-lobes, compared to only 13-18% defects in control brains . This suggests NAB2's involvement in axon projection and guidance occurs during specific developmental timeframes.

What is known about NAB2's potential role in pathological conditions?

NAB2 is encoded by a gene located on chromosome 12q13.3-14.1, a region frequently altered in various solid tumors, lipomas, and liposarcomas . This genomic location suggests potential involvement in oncogenic processes. Proteomic analyses have shown that NAB2 loss affects proteins involved in genome maintenance (DNA replication initiation, G2 DNA damage checkpoint, centromere complex assembly) and development processes . Meanwhile, NAB2 overexpression affects proteins related to development and muscle organization (striated muscle development, sarcomere organization, myosin filament assembly) . These differential protein expressions may explain how NAB2 dysregulation contributes to various pathological conditions, highlighting its importance in both developmental disorders and cancer biology.

What types of NAB2 antibodies are available for research applications?

NAB2 antibodies are available in multiple formats to accommodate different experimental needs. The primary types include:

• Polyclonal antibodies: These recognize multiple epitopes on the NAB2 protein and are typically produced in rabbits. For example, rabbit polyclonal antibodies to NAB2 (such as A44069) are available for Western blot applications .

• Monoclonal antibodies: These recognize a single epitope and offer high specificity. The NAB2 Antibody (1C4) is a mouse monoclonal IgG1 kappa light chain antibody that detects NAB2 protein across multiple species .

• Conjugated antibodies: NAB2 antibodies are available in both non-conjugated forms and conjugated to various molecules for specific detection methods:

  • Enzyme conjugates: HRP (horseradish peroxidase)

  • Fluorophore conjugates: FITC, PE, Alexa Fluor® variants

  • Agarose conjugates: For immunoprecipitation experiments

The selection should be based on the specific application, target species, and detection method required for your research.

How do I determine the appropriate NAB2 antibody for my experimental design?

When selecting a NAB2 antibody for your research, consider these critical factors:

• Experimental application: Different antibodies show varying performance across applications. For example, NBP2-19462 has been validated for:

  • Western blotting (1:500-1:3000 dilution)

  • Immunocytochemistry/Immunofluorescence (1:100-1:1000)

  • Immunohistochemistry-paraffin (1:100-1:1000)

  • Immunoprecipitation (1:100-1:500)

• Species reactivity: Verify that the antibody recognizes NAB2 in your experimental model. Some antibodies, like A44069, react with human, mouse, and rat samples , while others may have different species specificities.

• Antibody format: Consider whether you need a conjugated or unconjugated antibody based on your detection method. For direct detection, conjugated antibodies (FITC, PE, HRP) eliminate the need for secondary antibodies .

• Epitope location: For studying specific domains or post-translational modifications of NAB2, select antibodies targeting the relevant region.

• Validation data: Review scientific validation images and published literature using the antibody to ensure its reliability for your specific application .

What are the optimal protocols for using NAB2 antibodies in Western blotting?

For optimal Western blotting with NAB2 antibodies, follow these methodological guidelines:

• Sample preparation:

  • Use 30 μg of whole cell lysate per lane

  • Prepare samples in standard SDS-PAGE loading buffer with reducing agent

  • A 7.5% SDS-PAGE gel is suitable for resolving NAB2 protein

• Antibody dilutions:

  • Primary antibody: Use NAB2 antibody at 1:500-1:3000 dilution (NBP2-19462) or 1:2000 (as validated with A431 cell lysates)

  • Secondary antibody: Use appropriate anti-species antibody (anti-rabbit or anti-mouse depending on your primary)

• Detection optimization:

  • For enhanced sensitivity, consider using HRP-conjugated NAB2 antibodies

  • When using unconjugated antibodies, pair with suitable secondary antibodies such as Goat Anti-Rabbit IgG H&L Antibody (HRP)

• Controls:

  • Include positive control lysates where NAB2 expression is confirmed (A431 cells have been validated)

  • Include negative controls (either NAB2-negative samples or primary antibody omission)

• Troubleshooting:

  • If high background occurs, increase blocking time or adjust antibody dilutions

  • For weak signals, extend primary antibody incubation time or consider using a more sensitive detection system

How can I optimize immunofluorescence protocols when working with NAB2 antibodies?

For successful immunocytochemistry/immunofluorescence experiments with NAB2 antibodies:

• Sample preparation:

  • Fix cells with paraformaldehyde (as validated with HeLa cells)

  • Permeabilize with appropriate agent (0.1-0.5% Triton X-100 or 0.1% saponin)

  • Block with 1-5% normal serum or BSA

• Antibody application:

  • Use NAB2 antibody at 1:100-1:1000 dilution range

  • Optimal dilution for NBP2-19462 is 1:500 for paraformaldehyde-fixed HeLa cells

  • Incubate at 4°C overnight or room temperature for 1-2 hours

• Visualization strategies:

  • Use appropriate fluorophore-conjugated secondary antibodies

  • For direct detection, consider using pre-conjugated primary antibodies (FITC, PE, or Alexa Fluor® conjugates)

  • Include nuclear counterstain (DAPI or Hoechst) to visualize nuclei

• Imaging considerations:

  • As NAB2 is predominantly nuclear, focus on nuclear localization patterns

  • Use confocal microscopy for precise subcellular localization

  • Capture Z-stacks to fully document the three-dimensional distribution

• Controls and validation:

  • Include primary antibody omission controls

  • Consider using siRNA knockdown samples as negative controls

  • Use positive control cell lines with known NAB2 expression

What considerations are important for immunohistochemistry with NAB2 antibodies in tissue sections?

For effective immunohistochemistry (IHC) with NAB2 antibodies in tissue sections:

• Tissue preparation and antigen retrieval:

  • For paraffin-embedded sections, use EDTA-based antigen retrieval

  • TrilogyTM (EDTA-based) buffer with 15-minute treatment has been validated

  • Complete deparaffinization and rehydration before antigen retrieval

• Antibody dilution and incubation:

  • Use NAB2 antibody at 1:100-1:1000 dilution

  • For NBP2-19462, 1:500 dilution has been validated for mouse forebrain tissue

  • Incubate overnight at 4°C in a humidified chamber

• Detection systems:

  • For chromogenic detection, use appropriate HRP-conjugated secondary antibodies and DAB substrate

  • For fluorescent detection, use fluorophore-conjugated secondary antibodies

  • Amplification systems (e.g., tyramide signal amplification) may enhance sensitivity for low abundance targets

• Counterstaining recommendations:

  • For chromogenic detection, use hematoxylin for nuclear counterstaining

  • For fluorescent detection, use DAPI or similar nuclear stains

  • Consider autofluorescence quenching treatments for highly autofluorescent tissues

• Controls and validation:

  • Include positive control tissues (e.g., tissues known to express NAB2)

  • Include negative controls (primary antibody omission)

  • Consider using multiple NAB2 antibodies targeting different epitopes to validate staining patterns

How can I design experiments to study NAB2's role in neuronal development?

To investigate NAB2's role in neuronal development, consider these advanced experimental approaches:

• Temporal expression analysis:

  • Examine NAB2 expression during critical developmental windows (24h, 48h, and 72h after puparium formation in Drosophila models)

  • Correlate expression patterns with specific developmental events in neuronal morphogenesis

• Genetic manipulation strategies:

  • Use null mutations (Nab2ex3) to assess complete loss-of-function effects

  • Generate conditional knockouts for temporal control of NAB2 deletion

  • Create overexpression models (Nab2oe) to determine gain-of-function effects

  • Employ CRISPR-Cas9 for precise editing of specific NAB2 domains

• Morphological analysis techniques:

  • Implement serial optical sectioning of developing neural structures

  • Use α-FasII staining to visualize mushroom body lobes in Drosophila

  • Quantify axonal projection defects (e.g., midline crossing, lobe thinning/absence)

  • Apply 3D reconstruction to fully characterize structural abnormalities

• Proteomic approaches:

  • Compare wild-type, NAB2-null, and NAB2-overexpression models using differential proteomics

  • Focus on proteins with log2 expression changes ≥0.32 or ≤-0.32 with significance threshold of -log10(p-value) ≥1.3

  • Employ FlyEnrichr or similar tools for pathway enrichment analysis

• Functional assays:

  • Perform rescue experiments with wild-type or domain-mutated NAB2 constructs

  • Design axon guidance assays to measure guidance cue responsiveness

  • Employ live imaging to monitor growth cone dynamics in real-time

What techniques can be used to study NAB2 interactions with transcription factors?

To investigate NAB2's interactions with transcription factors, particularly its role as a corepressor of Egr-1/NGFI-A, consider these methodological approaches:

• Co-immunoprecipitation (Co-IP):

  • Use NAB2 antibodies conjugated to agarose beads (e.g., NAB2 Antibody (1C4) AC)

  • Standard protocol:
    a) Prepare nuclear extracts from cells expressing both NAB2 and target transcription factors
    b) Incubate lysates with NAB2 antibody-conjugated agarose (1:100-1:500 dilution)
    c) Analyze precipitated complexes by Western blotting for transcription factors of interest

• Chromatin Immunoprecipitation (ChIP):

  • Use NAB2 antibodies to identify genomic regions where NAB2-transcription factor complexes bind

  • Follow with sequencing (ChIP-seq) to map genome-wide binding sites

  • Compare binding profiles between wild-type and transcription factor-mutant conditions

• Proximity-based protein interaction assays:

  • Implement BioID or APEX2 proximity labeling with NAB2 fusion proteins

  • Use split-GFP complementation assays to visualize protein interactions in living cells

  • Apply FRET or BRET techniques to measure real-time protein-protein interactions

• Functional reporter assays:

  • Construct luciferase reporters driven by promoters regulated by NAB2 target transcription factors

  • Measure transcriptional activity in response to NAB2 manipulation (knockdown, overexpression)

  • Create domain mutations to identify specific interaction regions

• In vitro binding studies:

  • Use recombinant NAB2 protein (similar to that used for immunogen production)

  • Perform pull-down assays with purified transcription factors

  • Employ surface plasmon resonance or isothermal titration calorimetry to measure binding affinities

How can I troubleshoot non-specific binding when using NAB2 antibodies?

When encountering non-specific binding with NAB2 antibodies, implement these systematic troubleshooting approaches:

• Optimize blocking conditions:

  • Increase blocking time or concentration (5% BSA or normal serum)

  • Consider alternative blocking agents (milk for Western blots, fish gelatin for immunostaining)

  • Use species-specific serum matching your secondary antibody

• Adjust antibody parameters:

  • Titrate primary antibody concentration (test dilution series from 1:100 to 1:3000)

  • Reduce incubation temperature (4°C instead of room temperature)

  • Shorten incubation time to minimize non-specific binding opportunities

• Increase washing stringency:

  • Add additional washing steps with TBS-T or PBS-T

  • Increase detergent concentration (0.1% to 0.3% Tween-20)

  • Extend washing times between antibody applications

• Validate antibody specificity:

  • Test antibody on NAB2 knockout/knockdown samples as negative controls

  • Perform preabsorption controls with recombinant NAB2 protein

  • Confirm staining patterns with multiple antibodies targeting different NAB2 epitopes

• Address Fc receptor binding:

  • For cell-based assays, add excessive amounts of human IgG1 or species-specific IgG to block Fc receptors

  • Mouse IgG2a (but not mouse IgG1) has shown effectiveness in preventing non-specific Fc receptor binding

  • For immunohistochemistry, use antibody fragments (Fab or F(ab')2) to avoid Fc receptor interactions

How should I quantify and analyze NAB2 expression data from Western blots?

For rigorous quantification and analysis of NAB2 expression in Western blots:

• Densitometric analysis protocol:

  • Capture digital images using linear detection systems (avoid film oversaturation)

  • Use software such as ImageJ, Image Studio (LI-COR), or similar platforms

  • Define regions of interest (ROIs) consistently across all lanes

  • Subtract background using rolling ball or local background methods

• Normalization strategies:

  • Always normalize NAB2 signals to appropriate loading controls (β-actin, GAPDH, tubulin)

  • For subcellular fractions, use compartment-specific controls (Lamin for nuclear fractions)

  • Calculate relative expression as: NAB2 signal ÷ loading control signal

• Statistical analysis approaches:

  • For comparisons across multiple treatments or genotypes, use ANOVA with appropriate post-hoc tests

  • Apply significance thresholds similar to proteomic analyses (p-value ≤ 0.05)

  • For fold-change significance, consider thresholds of log2 fold change ≥0.32 or ≤-0.32

• Results presentation:

  • Display representative blot images alongside quantification graphs

  • Include molecular weight markers to confirm specificity

  • Present data as mean ± standard error from at least three independent experiments

• Validation considerations:

  • Confirm results using multiple cell lines or tissue types

  • Verify specificity using knockout/knockdown controls

  • Consider alternative antibodies targeting different epitopes to validate expression patterns

What bioinformatic approaches can help interpret NAB2-related proteomic data?

To effectively analyze and interpret NAB2-related proteomic datasets:

• Protein abundance change analysis:

  • Apply statistical thresholds: log2(experimental/control) ≥0.32 or ≤-0.32

  • Use significance threshold of -log10(p-value) ≥1.3

  • Compare experimental conditions (e.g., Nab2ex3 versus control and Nab2oe versus control)

• Functional enrichment analysis:

  • Implement tools like FlyEnrichr (for Drosophila) or similar platforms for other model systems

  • Categorize differentially expressed proteins into biological processes:
    a) NAB2 loss affects: DNA replication initiation, G2 DNA damage checkpoint, centromere complex assembly
    b) NAB2 overexpression affects: striated muscle development, sarcomere organization, myosin filament assembly

• Pathway analysis strategies:

  • Map differentially expressed proteins to known signaling pathways

  • Identify pathway nodes with multiple affected proteins

  • Apply network analysis to discover novel functional connections

• Integration with transcriptomic data:

  • Correlate protein abundance changes with mRNA expression changes

  • Identify post-transcriptionally regulated targets (discordant mRNA-protein changes)

  • Implement multi-omics analysis approaches for comprehensive interpretation

• Visualization techniques:

  • Create heatmaps of differentially expressed proteins across conditions

  • Generate volcano plots to visualize both magnitude and statistical significance

  • Develop protein-protein interaction networks to contextualize findings

How can I interpret contradictory results when studying NAB2 function across different models?

When encountering contradictory results in NAB2 studies across different model systems:

• Context-dependent function analysis:

  • Consider cellular context (different cell types may exhibit distinct NAB2 functions)

  • Examine developmental timing (NAB2 shows stage-specific effects during neuronal development)

  • Evaluate species differences (protein interaction networks may vary across model organisms)

• Methodological reconciliation:

  • Compare antibody specificities and epitopes used across studies

  • Assess knockout/knockdown efficiency in different experimental systems

  • Evaluate differences in experimental readouts and quantification methods

• Isoform-specific effects:

  • Determine which NAB2 isoforms are being studied in each experimental system

  • Design isoform-specific detection or manipulation approaches

  • Re-analyze data in the context of specific isoform expression patterns

• Interaction partner variation:

  • Analyze expression of known NAB2 interaction partners (e.g., Egr-1/NGFI-A) across models

  • Consider compensatory mechanisms that may mask phenotypes in certain systems

  • Implement double-knockout or combinatorial approaches to reveal masked functions

• Systematic validation strategies:

  • Recreate key experiments with standardized protocols across multiple models

  • Use multiple, independent methodologies to confirm core findings

  • Develop rescue experiments with domain-specific mutants to pinpoint functional regions

What new methodologies are being developed for studying NAB2 in living systems?

Emerging technologies for investigating NAB2 function in living systems include:

• Advanced genetic tools:

  • Inducible, cell-type-specific CRISPR-Cas9 systems for temporal and spatial control of NAB2 editing

  • Base editing technologies for studying specific NAB2 variants without complete gene disruption

  • CRISPR activation/inhibition (CRISPRa/CRISPRi) for precise modulation of NAB2 expression levels

• Live imaging approaches:

  • CRISPR knock-in of fluorescent tags for endogenous NAB2 visualization

  • Optogenetic control of NAB2 activity or interactions

  • Super-resolution microscopy for nanoscale visualization of NAB2 complexes

• Single-cell analysis methods:

  • Single-cell proteomics to detect cell-specific NAB2 expression patterns

  • Single-cell transcriptomics paired with proteomics to correlate NAB2 with target gene expression

  • Spatial transcriptomics to map NAB2 activity across tissue microenvironments

• Protein interaction detection:

  • Proximity labeling with improved spatial and temporal resolution

  • Single-molecule tracking to monitor NAB2 dynamics in real-time

  • Protein-fragment complementation assays optimized for neuronal systems

• Computational approaches:

  • Machine learning algorithms to predict NAB2 binding sites and affected pathways

  • Integration of multi-omics data for systems-level understanding of NAB2 function

  • Molecular dynamics simulations to model NAB2-transcription factor interactions

How can I design experiments to investigate NAB2's potential role in pathological conditions?

To investigate NAB2's involvement in pathological conditions, especially cancer:

• Clinical sample analysis:

  • Compare NAB2 expression between normal and tumor tissues

  • Focus on tumors originating from chromosome 12q13.3-14.1 region (solid tumors, lipomas, liposarcomas)

  • Correlate expression patterns with clinical outcomes and tumor progression

• Functional genetic screens:

  • Perform CRISPR screens in cancer models to identify synthetic lethal interactions with NAB2

  • Use shRNA libraries to identify genes whose knockdown sensitizes cells to NAB2 manipulation

  • Apply patient-derived xenograft models to validate findings in more physiological contexts

• Pathway-focused investigations:

  • Examine NAB2's impact on DNA damage response pathways

  • Investigate connections to cell cycle regulation (particularly G2 checkpoint)

  • Assess effects on developmental and differentiation pathways in cancer contexts

• Structure-function analyses:

  • Create domain-specific mutations to identify regions critical for pathological processes

  • Design construct libraries to systematically test NAB2 variants found in patient samples

  • Employ protein engineering to develop potential therapeutic approaches

• Translational approaches:

  • Develop NAB2-targeting compounds for potential therapeutic applications

  • Create biomarker assays based on NAB2 expression or activity patterns

  • Design combination approaches targeting NAB2-dependent vulnerabilities

What are the best practices for using NAB2 antibodies in multiplexed immunostaining?

For successful multiplexed immunostaining with NAB2 antibodies:

• Antibody selection and validation:

  • Choose NAB2 antibodies raised in different host species than other target antibodies

  • Alternatively, use directly conjugated NAB2 antibodies with distinct fluorophores

  • Validate antibody performance in single-staining before multiplexing

• Sequential staining protocol:

  • Begin with the lowest abundance target (often NAB2) with signal amplification if needed

  • Apply tyramide signal amplification (TSA) to allow antibody stripping between rounds

  • Include complete antibody elution steps between sequential stainings

• Spectral considerations:

  • Select fluorophores with minimal spectral overlap (e.g., Alexa 488, Cy3, Cy5)

  • Implement spectral unmixing for closely overlapping fluorophores

  • Include single-color controls for accurate spectral compensation

• Controls for multiplexed staining:

  • Use "fluorescence minus one" (FMO) controls to set proper thresholds

  • Include absorption controls to confirm complete antibody stripping

  • Perform reverse-order staining on replicate samples to verify consistent patterns

• Analysis approaches:

  • Apply automated image analysis tools for unbiased quantification

  • Use colocalization analyses to measure spatial relationships between NAB2 and other proteins

  • Implement machine learning for pattern recognition in complex multiplex images

How can I develop a quantitative assay for measuring NAB2 protein levels in biological samples?

To develop a robust quantitative assay for NAB2 protein measurement:

• ELISA development strategy:

  • Use purified recombinant NAB2 protein to generate standard curves

  • Select capture and detection antibodies targeting different NAB2 epitopes

  • Optimize sample dilution, antibody concentrations, and incubation conditions

  • Validate with positive controls (cell lines with known NAB2 expression) and negative controls

• MSD platform implementation:

  • Adapt to the Meso Scale Discovery (MSD) electrochemiluminescence platform for enhanced sensitivity

  • Optimize coating concentration of capture antibody on MSD plates

  • Develop standard curves using purified NAB2 protein

  • Implement rigorous validation with spike-recovery experiments

• Capillary electrophoresis immunoassay:

  • Use automated systems (e.g., Jess, Wes) for quantitative Western blot-like analysis

  • Optimize antibody concentration and incubation conditions

  • Develop standard curves with recombinant protein and cell lysate dilutions

  • Implement internal loading controls for normalization

• Flow cytometry-based quantification:

  • Use fluorophore-conjugated NAB2 antibodies (e.g., FITC, PE conjugates)

  • Develop protocols for cell permeabilization to access nuclear NAB2

  • Include quantitative beads to convert fluorescence to absolute protein numbers

  • Validate with positive and negative control cell lines

• Mass spectrometry-based approaches:

  • Develop targeted MS assays (SRM/MRM) for absolute quantification

  • Design NAB2-specific peptide standards for absolute quantification

  • Implement immunoprecipitation with NAB2 antibodies prior to MS analysis for enrichment

  • Validate with orthogonal methods (Western blot, ELISA)